Literature DB >> 17537938

Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.

S Arunmozhi Balajee1, Mark D Lindsley, Naureen Iqbal, James Ito, Peter G Pappas, Mary E Brandt.   

Abstract

Concerted morphological and sequencing-based strategies revealed the identity of a nonsporulating clinical isolate as Petromyces alliaceus (anamorph Aspergillus alliaceus). This rare Aspergillus sp. was recovered as the etiological agent of invasive pulmonary aspergillosis and had reduced in vitro susceptibilities to amphotericin B and caspofungin, which correlated with clinical failure of therapy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17537938      PMCID： PMC1951206          DOI： 10.1128/JCM.00642-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Design of a primer for ribosomal DNA internal transcribed spacer with enhanced specificity for ascomycetes.

Authors:  I Larena; O Salazar; V González; M C Julián; V Rubio
Journal:  J Biotechnol       Date:  1999-10-08       Impact factor: 3.307

2.  Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

Authors:  J Morgan; K A Wannemuehler; K A Marr; S Hadley; D P Kontoyiannis; T J Walsh; S K Fridkin; P G Pappas; D W Warnock
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

3.  Reflections on the question: what does molecular mycology have to do with the clinician treating the patient?

Authors:  F C Odds
Journal:  Med Mycol       Date:  2003-02       Impact factor: 4.076

4.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

5.  Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping.

Authors:  S Arunmozhi Balajee; David Nickle; Janos Varga; Kieren A Marr
Journal:  Eukaryot Cell       Date:  2006-10

6.  Analysis of genetic variability within the genus Petromyces.

Authors:  J Varga; B Tóth; E Kevei; A Palágyi; Z Kozakiewicz
Journal:  Antonie Van Leeuwenhoek       Date:  2000-01       Impact factor: 2.271

7.  Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene.

Authors:  C P Kurtzman; C J Robnett
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

8.  Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.

Authors:  S Arunmozhi Balajee; Jennifer L Gribskov; Edward Hanley; David Nickle; Kieren A Marr
Journal:  Eukaryot Cell       Date:  2005-03

9.  Design issues in studies evaluating diagnostic tests for aspergillosis.

Authors:  Kieren A Marr; Wendy Leisenring
Journal:  Clin Infect Dis       Date:  2005-09-15       Impact factor: 9.079

10.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

Authors:  M A Pfaller; S A Messer; L Boyken; R J Hollis; D J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803
View more
  15 in total

Review 1.  Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Authors:  S A Balajee; A M Borman; M E Brandt; J Cano; M Cuenca-Estrella; E Dannaoui; J Guarro; G Haase; C C Kibbler; W Meyer; K O'Donnell; C A Petti; J L Rodriguez-Tudela; D Sutton; A Velegraki; B L Wickes
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

2.  Atypical Aspergillus flavus isolates associated with chronic azole therapy.

Authors:  Mary E Brandt; Lalitha Gade; Cindy B McCloskey; S Arunmozhi Balajee
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

Review 3.  Treatment of infections by cryptic Aspergillus species.

Authors:  Wagner L Nedel; Alessandro C Pasqualotto
Journal:  Mycopathologia       Date:  2014-09-13       Impact factor: 2.574

4.  Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Maria Siopi; Lamprini Kanioura; Karin Meinike Jørgensen; David S Perlin; Johan W Mouton; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

5.  An environmental Sporothrix as a cause of corneal ulcer.

Authors:  Annie S Morrison; Shawn R Lockhart; Jennifer G Bromley; Joung Y Kim; Eileen M Burd
Journal:  Med Mycol Case Rep       Date:  2013-04-10

Review 6.  Multi-resistant aspergillosis due to cryptic species.

Authors:  Susan Julie Howard
Journal:  Mycopathologia       Date:  2014-06-27       Impact factor: 2.574

7.  Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).

Authors:  A Alastruey-Izquierdo; E Mellado; T Peláez; J Pemán; S Zapico; M Alvarez; J L Rodríguez-Tudela; M Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

8.  A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.

Authors:  Joseph Meletiadis; Maria Siopi; Lamprini Kanioura; Karin Meinike Jørgensen; David S Perlin; Johan W Mouton; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

Review 9.  Antifungal susceptibility profile of cryptic species of Aspergillus.

Authors:  Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Manuel Cuenca-Estrella
Journal:  Mycopathologia       Date:  2014-06-28       Impact factor: 2.574

10.  Aflatoxin and ochratoxin production by Aspergillus species under ex vivo conditions.

Authors:  Maren A Klich; Sean Tang; David W Denning
Journal:  Mycopathologia       Date:  2009-06-19       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.